Advertisement

Nonoperative Management of Rectal Cancer

The Watch and Wait Strategy
  • Author Footnotes
    1 Praça Amadeu Amaral, 47/111, São Paulo, São Paulo 01327-010, Brazil.
    Bruna Borba Vailati
    Footnotes
    1 Praça Amadeu Amaral, 47/111, São Paulo, São Paulo 01327-010, Brazil.
    Affiliations
    Angelita & Joaquim Gama Institute, Sao Paulo, Brazil

    Hospital Alemão Oswaldo Cruz, Sao Paulo, Brazil

    Hospital Beneficência Portuguesa, Sao Paulo, Brazil
    Search for articles by this author
  • Author Footnotes
    1 Praça Amadeu Amaral, 47/111, São Paulo, São Paulo 01327-010, Brazil.
    Guilherme Pagin São Julião
    Footnotes
    1 Praça Amadeu Amaral, 47/111, São Paulo, São Paulo 01327-010, Brazil.
    Affiliations
    Angelita & Joaquim Gama Institute, Sao Paulo, Brazil

    Hospital Alemão Oswaldo Cruz, Sao Paulo, Brazil

    Hospital Beneficência Portuguesa, Sao Paulo, Brazil
    Search for articles by this author
  • Author Footnotes
    1 Praça Amadeu Amaral, 47/111, São Paulo, São Paulo 01327-010, Brazil.
    Angelita Habr-Gama
    Footnotes
    1 Praça Amadeu Amaral, 47/111, São Paulo, São Paulo 01327-010, Brazil.
    Affiliations
    Angelita & Joaquim Gama Institute, Sao Paulo, Brazil

    Hospital Alemão Oswaldo Cruz, Sao Paulo, Brazil

    Colorectal Surgery Division, University of São Paulo School of Medicine, Sao Paulo, Brazil
    Search for articles by this author
  • Rodrigo Oliva Perez
    Correspondence
    Corresponding author. Praça Amadeu Amaral, 47/111, São Paulo, São Paulo 01327-010, Brazil.
    Affiliations
    Angelita & Joaquim Gama Institute, Sao Paulo, Brazil

    Hospital Alemão Oswaldo Cruz, Sao Paulo, Brazil

    Hospital Beneficência Portuguesa, Sao Paulo, Brazil
    Search for articles by this author
  • Author Footnotes
    1 Praça Amadeu Amaral, 47/111, São Paulo, São Paulo 01327-010, Brazil.
Published:March 09, 2022DOI:https://doi.org/10.1016/j.soc.2021.11.003

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Oncology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Burton S.
        • Brown G.
        • Daniels I.R.
        • et al.
        MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?.
        Br J Cancer. 2006; 94: 351-357
        • Heald R.J.
        • Ryall R.D.
        Recurrence and survival after total mesorectal excision for rectal cancer.
        Lancet. 1986; 1: 1479-1482
        • Heald R.J.
        • Husband E.M.
        • Ryall R.D.
        The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?.
        Br J Surg. 1982; 69: 613-616
        • Habr-Gama A.
        • de Souza P.M.
        • Ribeiro Jr., U.
        • et al.
        Low rectal cancer: impact of radiation and chemotherapy on surgical treatment.
        Dis Colon Rectum. 1998; 41: 1087-1096
        • Habr-Gama A.
        • Sabbaga J.
        • Gama-Rodrigues J.
        • et al.
        Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?.
        Dis Colon Rectum. 2013; 56: 1109-1117
        • Habr-Gama A.
        • Perez R.O.
        • Nadalin W.
        • et al.
        Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.
        Ann Surg. 2004; 240: 711-717
        • Habr-Gama A.
        • Perez R.O.
        • Wynn G.
        • et al.
        Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization.
        Dis Colon Rectum. 2010; 53: 1692-1698
        • Sauer R.
        • Becker H.
        • Hohenberger W.
        • et al.
        Preoperative versus postoperative chemoradiotherapy for rectal cancer.
        N Engl J Med. 2004; 351: 1731-1740
        • Sauer R.
        • Liersch T.
        • Merkel S.
        • et al.
        Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.
        J Clin Oncol. 2012; 30: 1926-1933
        • Cercek A.
        • Roxburgh C.S.D.
        • Strombom P.
        • et al.
        Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
        JAMA Oncol. 2018; 4: e180071
        • Heald R.J.
        • Beets G.
        • Carvalho C.
        Report from a consensus meeting: response to chemoradiotherapy in rectal cancer - predictor of cure and a crucial new choice for the patient: on behalf of the Champalimaud 2014 Faculty for 'Rectal cancer: when NOT to operate.
        Colorectal Dis. 2014; 16: 334-337
        • Kalady M.F.
        • de Campos-Lobato L.F.
        • Stocchi L.
        • et al.
        Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer.
        Ann Surg. 2009; 250: 582-589
        • Sloothaak D.A.
        • Geijsen D.E.
        • van Leersum N.J.
        • et al.
        Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer.
        Br J Surg. 2013; 100: 933-939
        • Perez R.O.
        • Habr-Gama A.
        • São Julião G.P.
        • et al.
        Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks?.
        Int J Radiat Oncol Biol Phys. 2012; 84: 1159-1165
        • Lefevre J.H.
        • Mineur L.
        • Kotti S.
        • et al.
        Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6).
        J Clin Oncol. 2016; 34: 3773-3780
        • Perez R.O.
        • Habr-Gama A.
        • Sao Juliao G.P.
        • et al.
        Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging.
        Tech Coloproctol. 2014; 18: 699-708
        • Van den Begin R.
        • Kleijnen J.P.
        • Engels B.
        • et al.
        Tumor volume regression during preoperative chemoradiotherapy for rectal cancer: a prospective observational study with weekly MRI.
        Acta Oncol. 2018; 57: 723-727
        • Habr-Gama A.
        • Sao Juliao G.P.
        • Fernandez L.M.
        • et al.
        Achieving a Complete Clinical Response After Neoadjuvant Chemoradiation That Does Not Require Surgical Resection: It May Take Longer Than You Think!.
        Dis Colon Rectum. 2019; 62: 802-808
        • Perez R.O.
        • Habr-Gama A.
        • Pereira G.V.
        • et al.
        Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer?.
        Colorectal Dis. 2012; 14: 714-720
        • Habr-Gama A.
        • Sao Juliao G.P.
        • Perez R.O.
        Pitfalls of transanal endoscopic microsurgery for rectal cancer following neoadjuvant chemoradiation therapy.
        Minim Invasive Ther Allied Technol. 2014; 23: 63-69
        • Marks J.H.
        • Valsdottir E.B.
        • DeNittis A.
        • et al.
        Transanal endoscopic microsurgery for the treatment of rectal cancer: comparison of wound complication rates with and without neoadjuvant radiation therapy.
        Surg Endosc. 2009; 23: 1081-1087
        • Perez R.O.
        • Habr-Gama A.
        • Sao Juliao G.P.
        • et al.
        Transanal endoscopic microsurgery for residual rectal cancer after neoadjuvant chemoradiation therapy is associated with significant immediate pain and hospital readmission rates.
        Dis Colon Rectum. 2011; 54: 545-551
        • Sao Juliao G.P.
        • Ortega C.D.
        • Vailati B.B.
        • et al.
        Magnetic resonance imaging following neoadjuvant chemoradiation and transanal endoscopic microsurgery for rectal cancer.
        Colorectal Dis. 2017; 19: O196-O203
        • Habr-Gama A.
        • Lynn P.B.
        • Jorge J.M.
        • et al.
        Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation.
        Dis Colon Rectum. 2016; 59: 264-269
        • Hompes R.
        • McDonald R.
        • Buskens C.
        • et al.
        Completion surgery following transanal endoscopic microsurgery: assessment of quality and short- and long-term outcome.
        Colorectal Dis. 2013; 15: e576-e581
        • Morino M.
        • Allaix M.E.
        • Arolfo S.
        • et al.
        Previous transanal endoscopic microsurgery for rectal cancer represents a risk factor for an increased abdominoperineal resection rate.
        Surg Endosc. 2013; 27: 3315-3321
        • Patel U.B.
        • Brown G.
        • Rutten H.
        • et al.
        Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer.
        Ann Surg Oncol. 2012; 19: 2842-2852
        • Patel U.B.
        • Blomqvist L.K.
        • Taylor F.
        • et al.
        MRI after treatment of locally advanced rectal cancer: how to report tumor response--the MERCURY experience.
        AJR Am J Roentgenol. 2012; 199: W486-W495
        • Lambregts D.M.
        • Maas M.
        • Bakers F.C.
        • et al.
        Long-term follow-up features on rectal MRI during a wait-and-see approach after a clinical complete response in patients with rectal cancer treated with chemoradiotherapy.
        Dis Colon Rectum. 2011; 54: 1521-1528
        • Lambregts D.M.
        • van Heeswijk M.M.
        • Delli Pizzi A.
        • et al.
        Diffusion-weighted MRI to assess response to chemoradiotherapy in rectal cancer: main interpretation pitfalls and their use for teaching.
        Eur Radiol. 2017; 27: 4445-4454
        • Lambregts D.M.
        • Lahaye M.J.
        • Heijnen L.A.
        • et al.
        MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy.
        Eur Radiol. 2016; 26: 2118-2125
        • Maas M.
        • Lambregts D.M.
        • Nelemans P.J.
        • et al.
        Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment.
        Ann Surg Oncol. 2015; 22: 3873-3880
        • Lambregts D.M.
        • Rao S.X.
        • Sassen S.
        • et al.
        MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
        Ann Surg. 2015; 262: 1034-1039
        • Perez R.O.
        • Habr-Gama A.
        • Gama-Rodrigues J.
        • et al.
        Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-term results of a prospective trial (National Clinical Trial 00254683).
        Cancer. 2012; 118: 3501-3511
        • Rymer B.
        • Curtis N.J.
        • Siddiqui M.R.
        • et al.
        FDG PET/CT Can Assess the Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy: Evidence From Meta-analysis and Systematic Review.
        Clin Nucl Med. 2016; 41: 371-375
        • Dos Anjos D.A.
        • Perez R.O.
        • Habr-Gama A.
        • et al.
        Semiquantitative Volumetry by Sequential PET/CT May Improve Prediction of Complete Response to Neoadjuvant Chemoradiation in Patients With Distal Rectal Cancer.
        Dis Colon Rectum. 2016; 59: 805-812
        • van der Valk M.J.M.
        • Hilling D.E.
        • Bastiaannet E.
        • et al.
        Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.
        Lancet. 2018; 391: 2537-2545
        • Fernandez L.M.
        • Sao Juliao G.P.
        • Figueiredo N.L.
        • et al.
        Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.
        Lancet Oncol. 2021; 22: 43-50
        • Habr-Gama A.
        • Gama-Rodrigues J.
        • Sao Juliao G.P.
        • et al.
        Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.
        Int J Radiat Oncol Biol Phys. 2014; 88: 822-828
        • Dattani M.
        • Heald R.J.
        • Goussous G.
        • et al.
        Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis.
        Ann Surg. 2018; 268: 955-967
        • Chadi S.A.
        • Malcomson L.
        • Ensor J.
        • et al.
        Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis.
        Lancet Gastroenterol Hepatol. 2018; 3: 825-836
        • Habr-Gama A.
        • Sao Juliao G.P.
        • Vailati B.B.
        • et al.
        Organ Preservation Among Patients With Clinically Node-Positive Rectal Cancer: Is It Really More Dangerous?.
        Dis Colon Rectum. 2019; 62: 675-683
        • Kong J.C.
        • Guerra G.R.
        • Warrier S.K.
        • et al.
        Outcome and Salvage Surgery Following "Watch and Wait" for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review.
        Dis Colon Rectum. 2017; 60: 335-345
        • Fernandez L.M.
        • Figueiredo N.L.
        • Habr-Gama A.
        • et al.
        Salvage Surgery With Organ Preservation for Patients With Local Regrowth After Watch and Wait: Is It Still Possible?.
        Dis Colon Rectum. 2020; 63: 1053-1062
        • Nasir I.
        • Fernandez L.
        • Vieira P.
        • et al.
        Salvage surgery for local regrowths in Watch & Wait - Are we harming our patients by deferring the surgery?.
        Eur J Surg Oncol. 2019; 45: 1559-1566
        • Smith J.J.
        • Strombom P.
        • Chow O.S.
        • et al.
        Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy.
        JAMA Oncol. 2019; : e185896
        • Maas M.
        • Nelemans P.J.
        • Valentini V.
        • et al.
        Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.
        Lancet Oncol. 2010; 11: 835-844
        • Renehan A.G.
        • Malcomson L.
        • Emsley R.
        • et al.
        Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
        Lancet Oncol. 2016; 17: 174-183
        • Hupkens B.J.P.
        • Martens M.H.
        • Stoot J.H.
        • et al.
        Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection - A Matched-Controlled Study.
        Dis Colon Rectum. 2017; 60: 1032-1040
        • Vailati B.B.
        • Habr-Gama A.
        • Mattacheo A.E.
        • et al.
        Quality of Life in Patients With Rectal Cancer After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection-Are We Comparing Apples to Oranges?.
        Dis Colon Rectum. 2018; 61: e21
        • Lopes-Ramos C.
        • Koyama F.C.
        • Habr-Gama A.
        • et al.
        Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer.
        Cancer Genet. 2015; 208: 319-326
        • Perez R.O.
        • Habr-Gama A.
        • Sao Juliao G.P.
        • et al.
        Should We Give Up The Search for a Clinically Useful Gene Signature for the Prediction of Response of Rectal Cancer to Neoadjuvant Chemoradiation?.
        Dis Colon Rectum. 2016; 59: 895-897
        • Chow O.S.
        • Kuk D.
        • Keskin M.
        • et al.
        KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.
        Ann Surg Oncol. 2016; 23: 2548-2555
        • Hasan S.
        • Renz P.
        • Wegner R.E.
        • et al.
        Microsatellite Instability (MSI) as an Independent Predictor of Pathologic Complete Response (PCR) in Locally Advanced Rectal Cancer: A National Cancer Database (NCDB) Analysis.
        Ann Surg. 2018; 271: 716-723
        • Bettoni F.
        • Masotti C.
        • Habr-Gama A.
        • et al.
        Intratumoral Genetic Heterogeneity in Rectal Cancer: Are Single Biopsies representative of the entirety of the tumor?.
        Ann Surg. 2017; 265: e4-e6
        • El Sissy C.
        • Kirilovsky A.
        • Van den Eynde M.
        • et al.
        A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy.
        Clin Cancer Res. 2020; 26: 5198-5207
        • Ganesh K.
        • Wu C.
        • O'Rourke K.P.
        • et al.
        A rectal cancer organoid platform to study individual responses to chemoradiation.
        Nat Med. 2019; 25: 1607-1614
        • Carpinetti P.
        • Donnard E.
        • Bettoni F.
        • et al.
        The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation.
        Oncotarget. 2015; 6: 38360-38371